ANIP Stock Price History and Quote Analysis: Insights for Investors
ANI Pharmaceuticals, Inc.
Stock Price Today
ANI Pharmaceuticals, Inc. (ANIP) stock surged +3.37%, trading at $56.15 on NASDAQ, up from the previous close of $54.32. The stock opened at $54.50, fluctuating between $54.42 and $56.22 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Company Information
| Employees | 642 |
| Beta | 0.713 |
| Sales or Revenue | $486.82M |
| 5Y Sales Change% | 0.567% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stock price is $56.15 in the last trading session. During the trading session, ANIP stock reached the peak price of $56.22 while $54.42 was the lowest point it dropped to. The percentage change in ANIP stock occurred in the recent session was 3.37% while the dollar amount for the price change in ANIP stock was $1.83.
The NASDAQ listed ANIP is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. ANI Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Nikhil Lalwani
Pres, Chief Executive Officer & Director
Ms. Elizabeth Powell J.D.
Chief Compliance Officer & Head of Legal of Rare Disease
Mr. James G. Marken
Senior Vice President of Operations & Product Devel.
Ms. Krista L. Davis
Chief HR Officer
Mr. Muthusamy Shanmugam MS R.Ph.
Head of R&D, Chief Operating Officer of Novitium Operations & Director
Mr. Stephen P. Carey
Senior Vice President of Fin. & Chief Financial Officer
Mr. Chad Gassert
Senior Vice President of Corporation Devel. & Strategy
Mr. Christopher K. Mutz
Head of Rare Disease
Mr. Ori Gutwerg
Senior Vice President of Generics
Ms. Meredith W. Cook
Senior Vice President, Gen. Counsel & Corporation Sec.
ANIP's closing price is 16.49% higher than its 52-week low of $48.20 where as its distance from 52-week high of $70.81 is -20.7%.
Number of ANIP employees currently stands at 642.
Official Website of ANIP is: https://www.anipharmaceuticals.com
ANIP could be contacted at phone 218 634 3500 and can also be accessed through its website. ANIP operates from 210 Main Street West, Baudette, MN 56623, United States.
ANIP stock volume for the day was 529.38K shares. The average number of ANIP shares traded daily for last 3 months was 306.2K.
The market value of ANIP currently stands at $1.18B with its latest stock price at $56.15 and 21.03M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com